Article | May 5, 2022

The Role Of Maintenance Therapy In Gynecologic Cancer Treatment

Source: Premier Research

By Rupa Doshi, Irene Figari and Mary Gunn

GettyImages-1044548366 woman cancer patient

Advanced ovarian and endometrial carcinomas present the greatest challenge in treating gynecologic cancer and, among the five types of female cancers, are responsible for the most U.S. deaths annually.1 With a combination of surgery, chemotherapy, and radiation; patients can go into remission, but the majority will have a recurrence after several months or years. There is a critical unmet need for better maintenance therapies to improve the quality of life and, ideally, achieve improvement in progression-free and overall survival for these women. Research has identified several useful specific agents, and biomarkers can help guide the selection of patients for maintenance therapy treatment. 

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader